These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28590542)

  • 21. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
    Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score.
    Hu Z; Zhou J; Li Z; Xiang J; Zhang Q; Yan S; Wu J; Zhang M; Wang W; Zheng S
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):206-216. PubMed ID: 28107613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor Age-Based Analysis of Liver Transplantation Outcomes: Short- and Long-Term Outcomes Are Similar Regardless of Donor Age.
    Chapman WC; Vachharajani N; Collins KM; Garonzik-Wang J; Park Y; Wellen JR; Lin Y; Shenoy S; Lowell JA; Doyle MB
    J Am Coll Surg; 2015 Jul; 221(1):59-69. PubMed ID: 25872684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.
    Schaubel DE; Sima CS; Goodrich NP; Feng S; Merion RM
    Am J Transplant; 2008 Feb; 8(2):419-25. PubMed ID: 18190658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk analysis of ischemic-type biliary lesions after liver transplant using octogenarian donors.
    Ghinolfi D; De Simone P; Lai Q; Pezzati D; Coletti L; Balzano E; Arenga G; Carrai P; Grande G; Pollina L; Campani D; Biancofiore G; Filipponi F
    Liver Transpl; 2016 May; 22(5):588-98. PubMed ID: 26784011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation in the United Kingdom.
    Neuberger J
    Liver Transpl; 2016 Aug; 22(8):1129-35. PubMed ID: 27081833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?
    Uemura T; Nikkel LE; Hollenbeak CS; Ramprasad V; Schaefer E; Kadry Z
    Transpl Int; 2012 Jun; 25(6):671-9. PubMed ID: 22487509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplantation in Germany.
    Tacke F; Kroy DC; Barreiros AP; Neumann UP
    Liver Transpl; 2016 Aug; 22(8):1136-42. PubMed ID: 27082951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft selection strategy in adult-to-adult living donor liver transplantation: When both hemiliver grafts meet volumetric criteria.
    Kurihara T; Yoshizumi T; Yoshida Y; Ikegami T; Itoh S; Harimoto N; Ninomiya M; Uchiyama H; Okabe H; Kimura K; Kawanaka H; Shirabe K; Maehara Y
    Liver Transpl; 2016 Jul; 22(7):914-22. PubMed ID: 26953726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplication product of Model for End-stage Liver Disease and Donor Risk Index as predictive models of survival after liver transplantation.
    Khalaileh A; Khoury T; Harkrosh S; Nowotny Y; Massarwa M; Safadi R; Mor E; Nakache R; Abu Gazala S; Merhav H
    Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1116-1120. PubMed ID: 30870222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posttransplant mortality risk assessment for adult-to-adult right-lobe living donor liver recipients with benign end-stage liver disease.
    Zhang M; Yin F; Chen B; Li Y; Yan L; Wen T; Li B
    Scand J Gastroenterol; 2012 Jul; 47(7):842-52. PubMed ID: 22546008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Octogenarian liver grafts: Is their use for transplant currently justified?
    Jiménez-Romero C; Cambra F; Caso O; Manrique A; Calvo J; Marcacuzco A; Rioja P; Lora D; Justo I
    World J Gastroenterol; 2017 May; 23(17):3099-3110. PubMed ID: 28533667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
    Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
    Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maximizing donors with viral hepatitis in the current era.
    Brown K
    Liver Transpl; 2017 Oct; 23(S1):S44-S49. PubMed ID: 28846183
    [No Abstract]   [Full Text] [Related]  

  • 36. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
    Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined liver-dual kidney transplant: Role in expanded donors.
    Di Laudo M; Ravaioli M; La Manna G; Comai G; Cescon M; Del Gaudio M; Zanfi C; Cucchetti A; Ercolani G; Pinna AD
    Liver Transpl; 2017 Jan; 23(1):28-34. PubMed ID: 27113672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver Transplant Survival Index for Patients with Model for End-Stage Liver Disease Score ≥ 35: Modeling Risk and Adjusting Expectations in the Share 35 Era.
    Steggerda JA; Kim IK; Todo T; Malinoski D; Klein AS; Bloom MB
    J Am Coll Surg; 2019 Apr; 228(4):437-450.e8. PubMed ID: 30594593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.
    Croome KP; Lee DD; Keaveny AP; Taner CB
    Transplantation; 2016 Dec; 100(12):2640-2647. PubMed ID: 27861295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor-recipient matching: myths and realities.
    Briceño J; Ciria R; de la Mata M
    J Hepatol; 2013 Apr; 58(4):811-20. PubMed ID: 23104164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.